Insmed
INSM
#740
Rank
โ‚ฌ27.21 B
Marketcap
126,28ย โ‚ฌ
Share price
-1.56%
Change (1 day)
79.16%
Change (1 year)

Insmed (INSM) - Cash on Hand

Cash on Hand as of December 2025 : โ‚ฌ1.24 Billion

According to Insmed's latest financial reports the company has โ‚ฌ1.24 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Insmed - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31โ‚ฌ1.21 B-11.65%
2024-12-31โ‚ฌ1.37 B95.17%
2023-12-31โ‚ฌ0.70 B-34.05%
2022-12-31โ‚ฌ1.07 B69.13%
2021-12-31โ‚ฌ0.63 B46.12%
2020-12-31โ‚ฌ0.43 B-0.45%
2019-12-31โ‚ฌ0.43 B0.54%
2018-12-31โ‚ฌ0.43 B36.23%
2017-12-31โ‚ฌ0.31 B105.51%
2016-12-31โ‚ฌ0.15 B-40.25%
2015-12-31โ‚ฌ0.25 B97.61%
2014-12-31โ‚ฌ0.13 B58.75%
2013-12-31โ‚ฌ82.47 M17.38%
2012-12-31โ‚ฌ70.25 M19.63%
2011-12-31โ‚ฌ58.73 M-27.7%
2010-12-31โ‚ฌ81.23 M-4.75%
2009-12-31โ‚ฌ85.27 M4873.75%
2008-12-31โ‚ฌ1.71 M-84.81%
2007-12-31โ‚ฌ11.28 M-38.24%
2006-12-31โ‚ฌ18.27 M14.93%
2005-12-31โ‚ฌ15.89 M133.88%
2004-12-31โ‚ฌ6.79 M-71.01%
2003-12-31โ‚ฌ23.45 M-10.32%
2002-12-31โ‚ฌ26.15 M-54.94%
2001-12-31โ‚ฌ58.03 M-34.2%
2000-12-31โ‚ฌ88.19 M1814.7%
1999-12-31โ‚ฌ4.6 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novartis
NVS
โ‚ฌ10.02 B 706.48%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
โ‚ฌ8.35 B 572.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚ฌ5.74 B 362.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚ฌ0.81 B-34.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚ฌ0.14 B-87.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
โ‚ฌ0.21 B-82.91%๐Ÿ‡บ๐Ÿ‡ธ USA